Published by Michele Maatouk on 12th March 2019
(Sharecast News) - Medical devices maker Smith & Nephew has agreed to buy US biotechnology company Osiris Therapeutics for $19 per share, which is an enterprise value of around $660m.
URL: http://www.digitallook.com/dl/news/story/28749812/...